Diagnostics

Gene expression panel could help breast cancer patients with a low risk of recurrence avoid unnecessary chemotherapy

Liquid crystal displays are ubiquitous, but could the technology be used to detect early-stage amyloid fibril formation?

Keith Miller is Director and co-founder of CADQAS (Cancer Diagnostic Quality Assurance Services), a not-for-profit community interest company hosted by Poundbury Cancer Institute (PCI).

Christopher Hudson is Director of Tissue Diagnostics UK and Ireland at Roche, the multinational life sciences company that supports the Poundbury Cancer Institute through funding and research collaboration.

A new device, the Cytosponge, could pair with biomarker testing to offer an effective, low-cost way to diagnose and stratify Barrett’s esophagus

Molecular diagnostics provide us with huge amounts of data – but, as a profession, we’re still working on the best ways of collecting and using it

Poundbury Cancer Institute aims to put pathology at the forefront of cancer research, and bring industry, national healthcare service and quality assurance together to expand the use of companion diagnostics and important biological markers.

A new approach aims to answer the urgent need for genomic pathology education

Manual microscopic analysis is the gold standard for analyzing blood smears, but it’s time to make way for automated microscopy

What do geochemistry, biology and space science have in common? They’ve all come together to develop a new, real-time test for bone disease